In new research, scientists at the Department of Energy's SLAC National Accelerator Laboratory, in collaboration with ...
Antibody–drug conjugates (ADCs) represent one of the most transformative advances in precision oncology over the past two decades and are increasingly positioned to replace conventional chemotherapy ...
How can cancer cells be targeted without damaging healthy tissue? This is one of the major challenges facing oncology today.
Scientists at Oregon Health & Science University have uncovered a previously unknown system of internal "trade winds" that ...